Triazole antifungal
Pregnancy: Single dose (150 mg) relatively safe. Prolonged high doses associated with fetal anomalies — avoid in first trimester.
Fluconazole
Brand names: Diflucan
Adult dose
Dose: Oropharyngeal candidiasis: 50–100 mg daily for 7–14 days; Systemic/invasive: 400–800 mg loading then 200–400 mg daily; Vaginal candidiasis: 150 mg single dose
Route: Oral or IV
Frequency: Once daily
Max: 800 mg/day (Cryptococcal meningitis)
Vaginal candidiasis: 150 mg single oral dose. Oropharyngeal: 50 mg/day for 7–14 days. Cryptococcal meningitis (induction): 400–800 mg/day after amphotericin. Candidaemia: 800 mg loading then 400 mg daily.
Paediatric dose
Dose: 3 mg/kg
Route: Oral or IV
Frequency: Once daily
Max: 12 mg/kg/day (max 800 mg/day)
Concentration: 2 mg/ml
Neonatal candidiasis: 6–12 mg/kg every 72 hours (premature). Oropharyngeal: 3 mg/kg once daily. Systemic/invasive: 6–12 mg/kg once daily. Maximum dose depends on indication.
Dose adjustments
Renal
Halve dose (or double interval) if eGFR <50 for maintenance; no adjustment for single dose.
Hepatic
Use with caution in hepatic impairment; monitor LFTs.
Paediatric weight-based calculator
Neonatal candidiasis: 6–12 mg/kg every 72 hours (premature). Oropharyngeal: 3 mg/kg once daily. Systemic/invasive: 6–12 mg/kg once daily. Maximum dose depends on indication.
Clinical pearls
- Inactive against Aspergillus — use voriconazole or isavuconazole for aspergillosis
- Candida krusei and some C. glabrata strains intrinsically resistant
- Monitor LFTs and drug interactions (major CYP2C9/3A4 inhibitor)
- Single 150 mg dose for vaginal candidiasis — highly effective and convenient
- Available as IV and oral (same bioavailability — can switch freely)
Contraindications
- Concomitant use with terfenadine, cisapride, pimozide, quinidine, astemizole (QT prolongation risk)
Side effects
- Nausea and abdominal discomfort
- Headache
- Elevated liver enzymes (hepatotoxicity — rare)
- Rash (discontinue if severe — SJS risk in HIV patients)
- QT prolongation
Interactions
- Warfarin — major increase in INR (reduce warfarin dose)
- Phenytoin — increases phenytoin levels
- Statins (simvastatin, atorvastatin) — increased myopathy risk
- Oral hypoglycaemics (sulphonylureas) — increased hypoglycaemia
- Ciclosporin — increased levels
- Rifampicin — reduces fluconazole levels
Monitoring
- LFTs (prolonged use)
- Drug interactions
- Clinical response (culture if not responding)
Reference: BNFc; BNF; IDSA Candidiasis Guidelines 2016; PHE guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023